{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:39:50Z","timestamp":1794685190427,"version":"4.9.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016658","name":"PNSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020230","name":"Junta de Andaluc\u00eda Consejer\u00eda de Transformaci\u00f3n Econ\u00f3mica Industria Conocimiento y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pnpbp.2024.111056","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:32:38Z","timestamp":1718299958000},"page":"111056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review"],"prefix":"10.1016","volume":"134","author":[{"given":"Paloma","family":"Ruiz-Sastre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"G\u00f3mez-S\u00e1nchez-Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Mart\u00edn-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Herrera-Imbroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn","family":"Mayoral-Cleries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Santos-Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Guzm\u00e1n-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111056_bb0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/mp.2010.101","article-title":"Days out of role due to common physical and mental conditions: results from the WHO world mental health surveys","volume":"16","author":"Alonso","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.626906","article-title":"Blood brain-derived neurotrophic factor (BDNF) and major depression: do we have a translational perspective?","volume":"15","author":"Arosio","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0015","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0020","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.4088\/JCP.16m11310","article-title":"Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder","volume":"78","author":"Benedetti","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1028963","article-title":"Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity","volume":"15","author":"Chatterjee","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/00048674211062532","article-title":"Cardioprotective potential of lithium and role of fractalkine in euthymic patients with bipolar disorder","volume":"57","author":"Chen","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0040","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.euroneuro.2014.09.001","article-title":"Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder","volume":"24","author":"Chen","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.672526","article-title":"Ketamine: Neuroprotective or Neurotoxic?","volume":"15","author":"Choudhury","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41398-022-01968-0","article-title":"Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy","volume":"12","author":"Duan","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2018.02.004","article-title":"Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment","volume":"102","author":"Edberg","year":"2018","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2020.06.010","article-title":"Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment","volume":"129","author":"Edberg","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/jrms.jrms_342_22","article-title":"The effects of omega 3 fatty acids on the serum concentrations of pro inflammatory cytokines anddepression status in patients with bipolar disorder: a randomized double-blind controlled clinical trial","volume":"28","author":"Eslahi","year":"2023","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0070","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mp.2013.172","article-title":"Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis","volume":"19","author":"Fernandes","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2854","article-title":"Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder","volume":"37","author":"Ferrari","year":"2022","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/13651501.2022.2101928","article-title":"Effect of quetiapine on inflammation and immunity: a systematic review","volume":"27","author":"Ferrari","year":"2023","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.npbr.2019.07.007","article-title":"Changes in inflammation with treatment for bipolar II depression: pilot trial data on differential effects of psychotherapy and medication","volume":"33","author":"Fiedorowicz","year":"2019","journal-title":"Neurol. Psychiatry Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0095","article-title":"Anti-inflammatory medications for the treatment of mental disorders: a scoping review","volume":"26","author":"Fitton","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.psychres.2018.08.034","article-title":"The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: a plea for further research attention","volume":"269","author":"Fornaro","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0110","first-page":"8","article-title":"Protein biomarkers in monocytes and CD4+ lymphocytes for predicting Lithium treatment response of bipolar disorder: a feasibility study with tyramine-based signal-amplified flow cytometry","volume":"52","author":"Gao","year":"2022","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/medicina59010120","article-title":"Divergent directionality of immune cell-specific protein expression between bipolar Lithium responders and non-responders revealed by enhanced flow cytometry","volume":"59","author":"Gao","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/jcm13051491","article-title":"Possible role of correlation coefficients and network analysis of multiple intracellular proteins in blood cells of patients with bipolar disorder in studying the mechanism of Lithium responsiveness: a proof-concept study","volume":"13","author":"Gao","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/fcp.12826","article-title":"Is lithium neuroprotective? An updated mechanistic illustrated review","volume":"37","author":"Ghanaatfar","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neubiorev.2017.07.002","article-title":"Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders","volume":"80","author":"Ghasemi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroscience.2018.10.012","article-title":"Medial prefrontal cortical cannabinoid CB1 receptors mediate morphine-dextromethorphan cross state-dependent memory: the involvement of BDNF\/cFOS signaling pathways","volume":"393","author":"Ghasemzadeh","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113522","article-title":"Ventral tegmental area serotonin 5-HT1A receptors and corticolimbic cFos\/BDNF\/GFAP signaling pathways mediate dextromethorphan\/morphine anti-allodynia","volume":"239","author":"Ghasemzadeh","year":"2021","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11481-013-9462-8","article-title":"Evidence for a dysregulated immune system in the etiology of psychiatric disorders","volume":"8","author":"Gibney","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.04.041","article-title":"Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors","volume":"143","author":"Gonda","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41398-022-01819-y","article-title":"A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder","volume":"12","author":"G\u00f6teson","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10753-020-01365-z","article-title":"Memantine, NMDA receptor antagonist, attenuates ox-LDL-induced inflammation and oxidative stress via activation of BDNF\/TrkB signaling pathway in HUVECs","volume":"44","author":"Hao","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1186\/s12888-023-05154-4","article-title":"Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy","volume":"23","author":"Hjell","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/acps.13508","article-title":"A longitudinal study of the association between pro-inflammatory cytokines and mood symptoms in bipolar disorder","volume":"147","author":"Huang","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0180","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.001","article-title":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","volume":"43","author":"Isgren","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.31887\/DCNS.2006.8.4\/mising","article-title":"Genetics of stress response and stress-related disorders","volume":"8","author":"Ising","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103518","article-title":"Inflammation, stress and depression: an exploration of ketamine\u2019s therapeutic profile","volume":"28","author":"Johnston","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/7854_2020_181","article-title":"New pharmacological interventions in bipolar disorder","volume":"48","author":"Juruena","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0200","first-page":"200","article-title":"Evaluation of inflammatory markers in patients with depressed episodes in major depressive disorder and bipolar disorder before and after treatment","volume":"22","author":"Kafami","year":"2023","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0205","series-title":"Effects of Celecoxib on Inflammatory Markers in Bipolar Patients Undergoing Electroconvulsive Therapy: A Placebo-Controlled, Double Blind, Randomised Study","author":"Kargar","year":"2014"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-\u03b3 agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0215","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1001\/jama.293.20.2528","article-title":"The increasing medical burden in bipolar disorder","volume":"293","author":"Kupfer","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12 week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0225","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/acer.13640","article-title":"Add-on Memantine treatment for bipolar II disorder comorbid with alcohol dependence: a 12-week follow-up study","volume":"42","author":"Lee","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40345-019-0174-8","article-title":"Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial","volume":"8","author":"Lee","year":"2020","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0235","series-title":"Efficacy of Adjunctive Infliximab vs. Placebo in the Treatment of Anhedonia in Bipolar I\/II Depression","author":"Lee","year":"2020"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2014.12.033","article-title":"IL-23 and TGF-\u03b21 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode","volume":"174","author":"Li","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mehy.2012.04.042","article-title":"Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works","volume":"79","author":"Lu","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jad.2020.10.003","article-title":"Add-on memantine may improve cognitive functions and attenuate inflammation in middle- to old-aged bipolar II disorder patients","volume":"279","author":"Lu","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0255","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3390\/ijms22073723","article-title":"Gut microbiota and bipolar disorder: an overview on a novel biomarker for diagnosis and treatment","volume":"22","author":"Lucidi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/15622975.2013.830775","article-title":"Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach","volume":"15","author":"MacHado-Vieira","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0265","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/1673-5374.153686","article-title":"A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases","volume":"10","author":"Madeira","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104779","article-title":"Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression","author":"Mansur","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bdi.13165","article-title":"Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: a critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology","volume":"24","author":"McCarthy","year":"2022","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0280","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0285","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar Spectrum disorder in the National Comorbidity Survey Replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0290","doi-asserted-by":"crossref","unstructured":"Miola, A., Dal Porto, V., Meda, N., Perini, G., Solmi, M., Sambataro, F., 2022. Secondary mania induced by TNF-\u03b1 inhibitors: a systematic review. Psychiatry Clin. Neurosci. 76, 15\u201321. Doi: https:\/\/doi.org\/10.1111\/pcn.13302.","DOI":"10.1111\/pcn.13302"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111056_bib426","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/jpm13091408","article-title":"Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients","volume":"13","author":"Murata","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2020.01.004","article-title":"Effects of adjunctive inflammatory modulation on IL-1\u03b2 in treatment resistant bipolar depression","volume":"87","author":"Murata","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0305","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/biomedicines10092133","article-title":"Neuro inflammaging and psychopathological distress","volume":"10","author":"Murdaca","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0310","article-title":"Targeting inflammation in depression: ketamine as an anti-inflammatory antidepressant in psychiatric emergency","volume":"18","author":"Nikkheslat","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10571-021-01129-9","article-title":"Lithium as a neuroprotective agent for bipolar disorder: an overview","volume":"42","author":"Ochoa","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0325","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"B.M.J."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/15622975.2016.1259498","article-title":"sVCAM-1, sICAM-1, TNF-\u03b1 and IL-6 levels in bipolar disorder type I: acute, longitudinal and therapeutic implications","volume":"19","author":"Pantovi\u0107-Stefanovi\u0107","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0335","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","article-title":"Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression","volume":"84","author":"Park","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"105","key":"10.1016\/j.pnpbp.2024.111056_bb0340","first-page":"115","article-title":"Quality of life in euthymic bipolar patients: a systematic review and meta-analysis","volume":"255","author":"Pascual-S\u00e1nchez","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2024.02.019","article-title":"Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: safety, efficacy, and immunological biomarkers","volume":"118","author":"Poletti","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0350","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/14737175.9.1.109","article-title":"Assessment and treatment of suicide risk in bipolar disorders","volume":"9","author":"Pompili","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0360","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/PRA.0000000000000660","article-title":"The effect of adjunctive probiotics on markers of inflammation and oxidative stress in bipolar disorder: a double-blind, randomized, controlled trial","volume":"28","author":"Sabouri","year":"2022","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0365","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijms22041532","article-title":"Inflammation-related changes in mood disorders and the immunomodulatory role of Lithium","volume":"22","author":"Sakrajda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0375","article-title":"The principles and methods behind EFSA\u2019s guidance on uncertainty analysis in Scientific assessment","volume":"16","author":"Scientific Committee","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S385117","article-title":"Anti-inflammatory treatment efficacy in major depressive disorder: a systematic review of Meta-analyses","volume":"19","author":"Simon","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0385","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bdi.12496","article-title":"A pilot, open label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I\/II depression","volume":"19","author":"Soczynska","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0390","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bdi.12684","article-title":"Increasing mortality gap for patients diagnosed with bipolar disorder\u2014a nationwide study with 20 years of follow-up","volume":"21","author":"Staudt Hansen","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of Ketamine\u2019s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0400","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hup.2450","article-title":"Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment","volume":"30","author":"Teixeira","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2022.07.024","article-title":"Lithium exposure and chronic inflammation with activated macrophages and monocytes associated with atherosclerosis in bipolar disorder","volume":"314","author":"Tsai","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0415","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111056_bb0420","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3390\/biomedicines10061368","article-title":"Clinical value of inflammatory and neurotrophic biomarkers in bipolar disorder: a systematic review and Meta-analysis","volume":"10","author":"Vega-n\u00fa\u00f1ez","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2024.111056_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T08:52:08Z","timestamp":1723279928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":86,"alternative-id":["S0278584624001246"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111056","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111056"}}